A role for MC3R in modulating lung inflammation

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2008, Pages 866-873

  Getting, Stephen J ^a   Riffo Vasquez, Yanira ^b   Pitchford, Simon ^b   Kaneva, Magdalena ^a   Grieco, Paolo ^c   Page, Clive P ^b   Perretti, Mauro ^d   Spina, Domenico ^b  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti inflammation; Cell trafficking; Cytokines; GPCR; Leukocytes; Melanocortin

Indexed keywords

ALPHA INTERMEDIN; GAMMA INTERMEDIN; GAMMA INTERMEDIN[8 DEXTRO TRYPTOPHAN]; INTERLEUKIN 5; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MS 05; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALPHA-MSH; ANIMALS; ANTI-INFLAMMATORY AGENTS; EOSINOPHILS; GAMMA-MSH; INTERLEUKIN-5; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MELANOCORTINS; MELANOCYTE-STIMULATING HORMONES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PEPTIDES; PNEUMONIA; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTOR, MELANOCORTIN, TYPE 3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56949091561     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.09.004     Document Type: Article

References (35)

1. Ley K., Laudanna C., Cybulsky M.L., and Nourshagh S. Getting to the site of inflammation: the leukocyte adhesion cascade updates. Nat Rev Immunol 7 (2007) 678-689
2. Gilroy D.W., Lawerence T., Perretti M., and Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discovery 3 (2004) 401-416
3. Leoni G., Patel H.B., Sampaio A.L.F., Gavins F.N., Murray J.F., Grieco P., et al. Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J (2008) [epub ahead of print]
4. Barthel S.R., Johansson M.W., McNamee D.M., and Mosher D.F. Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J Leukoc Biol 83 (2008) 1-12
5. Riffo-Vasquez Y., Spina D., Page C., Tormay P., Singh M., Henderson B., et al. Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin Exp Allergy 34 (2004) 712-719
6. Perretti M. Endogenous mediators that inhibit leukocyte-endothelium interaction. Trends Pharmacol Sci 18 (1997) 418-425
7. Norling L.V., Sampaio A.L.F., Cooper D., and Perretti M. Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking. FASEB J 22 (2008) 682-690
8. Serhan C.N., Chiang N., and Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 (2008) 349-361
9. Catania A., Gatti S., Colombo G., and Lipton J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56 (2004) 1-29
10. Getting S.J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111 (2006) 1-15
11. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., et al. New aspects on the melanocortins and their receptors. Pharmacol Res 42 (2000) 393-420
12. Getting S.J., Gibbs L., Clark A.J., Flower R.J., and Perretti M. POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162 (1999) 7446-7453
13. Getting S.J., Allcock G.H., Flower R., and Perretti M. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 69 (2001) 98-104
14. Getting S.J., Christian H.C., Lam CW Gavins F.N., Flower R.J., Schioth H.B., and Perretti M. Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol 170 (2003) 3323-3330
15. Rajora N., Boccoli G., Catania A., and Lipton J.M. α-MSH modulates experimental inflammatory bowel disease. Peptides 18 (1997) 381-385
16. Getting S.J., Christian H.C., Flower R.J., and Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46 (2002) 2765-2775
17. Ceriani G., Diaz J., Murphree S., Catania A., and Lipton J.M. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1 (1994) 28-32
18. Lipton J.M., Catania A., and Ichiyama T. Marshaling the anti-inflammatory influence of the neuroimmunomodulator alpha-MSH. News Physiol Sci 15 (2000) 192-195
19. Raap U., Brzoska T., Sohl S., Path G., Emmel J., Herz U., et al. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171 (2003) 353-359
20. Manna S.K., and Aggarwal B.B. α-Melanocyte stimulating hormone inhibits the nuclear transcription factor NF-kB activation by various inflammatory agents. J Immunol 161 (1998) 2873-2880
21. Kalden D.H., Scholzen T., Brzoska T., and Luger T.A. Mechanisms of the anti-inflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann NY Acad Sci 885 (1999) 254-261
22. Lam C.W., Getting S.J., and Perretti M. In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J Immunol 174 (2005) 2297-2304
23. Lam C.W., Perretti M., and Getting S.J. Melanocortin receptor signaling in RAW264.7 macrophage cell line. Peptides 27 (2006) 404-412
24. Getting S.J., Lam C.W., Chen A.S., Grieco P., and Perretti M. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J 20 (2006) 2234-2241
25. Grieco P., Balse P.M., Weinberg D., MacNeil T., and Hruby V.J. D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem 43 (2000) 4998-5002
26. Kang L., McIntyre K.W., Gillooly K.M., Yang Y., Haycock J., Roberts S., et al. A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 80 (2006) 897-904
27. Pitchford S.C., Riffo-Vasquez Y., Sousa A., Momi S., Gresele P., Spina D., et al. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 103 (2004) 639-647
28. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26 (2000) 97-102
29. Riffo-Vasquez Y., Spina D., Thomas M., Gilbey T., Kemeny D.M., and Page C.P. The role of CD23 on allergen-induced IgE levels, pulmonary eosinophilia and bronchial hyperresponsiveness in mice. Clin Exp Allergy 30 (2000) 728-738
30. Berry D. Lindgren B: statistics: theory and methods (1990)
31. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141 (2000) 3518-3521
32. Caruso C., Durand D., Schioth H.B., Rey R., Seilicovich A., and Lasaqa M. Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 148 (2007) 4918-4926
33. Catania A., Cutuli M., Garofalo L., Carlin A., Airaghi L., Barcellini W., et al. The neuropeptide alpha-MSH in host defense. Ann NY Acad Sci 917 (2000) 227-231
34. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183 (1996) 195-201
35. Webb T.J., Sumpter T.L., Thiele A.T., Swanson K.A., and Wilkes D.S. The phenotype and function of lung dendritic cells. Crit Rev Immunol 25 (2005) 465-491